DABRAFENIB

DABRAFENIB (14752K)

dabrafenib 10 mg dispersible tablet, 2 x 210
14752K
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Paediatric high grade glioma
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 840 # of repeats: 1 DPMQ: $6,691.82 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Tafinlar

DABRAFENIB (14753L)

dabrafenib 10 mg dispersible tablet, 2 x 210
14753L
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Paediatric high grade glioma
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 840 # of repeats: 3 DPMQ: $6,691.82 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Tafinlar

DABRAFENIB (14773M)

dabrafenib 10 mg dispersible tablet, 2 x 210
14773M
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Paediatric low grade glioma
Treatment phase: Initial treatment

Restriction

Indication: Paediatric low grade glioma
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 840 # of repeats: 3 DPMQ: $6,691.82 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Tafinlar